EUVIMEDEUVIMED entdecken
Crossref

Cytotoxicity Assessment of Sea Star Asterias Rubens Protein-Sip-Young-6 HIS in Hela Cells. Comparisons with Doxorubicine Action

Michel Leclerc

International Journal of Research in Oncology · 2022

DOI: 10.33425/2833-0390.1005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Research in Oncology, 2022. Verfasst von Michel Leclerc.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The objective of this work is to assess whether recombinant protein SIP-Young-6 HIS, produced in HEK293, induces cell death in HeLa cells, when compared to doxorubicine action to achieve this, the metabolic activity is measured with the Cell Cytotoxicity Assay Kit (Abnova, Ref# KA4151) which contains a water-soluble dye that changes its absorption spectra upon cellular reduction. It seems that a post-translational modification occurs in HEK 293 since obtained results with the sea star young protein were less convincing than the preliminary ones. These last used directly the sea star IGKappa gene cloned in a CMV vector.

Zitieren

APA

Leclerc, M. (2022). Cytotoxicity Assessment of Sea Star Asterias Rubens Protein-Sip-Young-6 HIS in Hela Cells. Comparisons with Doxorubicine Action. International Journal of Research in Oncology. https://doi.org/10.33425/2833-0390.1005

Vancouver

Leclerc M. Cytotoxicity Assessment of Sea Star Asterias Rubens Protein-Sip-Young-6 HIS in Hela Cells. Comparisons with Doxorubicine Action. International Journal of Research in Oncology. 2022. doi:10.33425/2833-0390.1005

BibTeX
@article{Leclerc2022,
  author = {Leclerc, Michel},
  title = {Cytotoxicity Assessment of Sea Star Asterias Rubens Protein-Sip-Young-6 HIS in Hela Cells. Comparisons with Doxorubicine Action},
  journal = {International Journal of Research in Oncology},
  year = {2022},
  doi = {10.33425/2833-0390.1005}
}
Kostenlos starten →